Summary and Implications
Classical swine fever virus (CSFV) E2 glycoprotein was expressed in an alphavirus based replicon expression system. Vaccinated pigs developed CSFV-specific antibodies. This is the first known use of this technology against CSFV.
Iowa State University
Loy, J. Dustin; Mogler, Mark; Gander, Jill; Kamrud, Kurt I.; and Harris, D.L. Hank
"Development of an Alphavirus Replicon Classical Swine Fever Virus Vaccine Candidate,"
Animal Industry Report:
AS 659, ASL R2752.
Available at: https://lib.dr.iastate.edu/ans_air/vol659/iss1/3